Twitter/X

Beaver (@beaverd) is publishing an Alzheimer's enzyme paper and asks chaperonin…

Brief

Beaver (@beaverd) is publishing an Alzheimer's enzyme paper and asks chaperonin labs to bench-test biochemical predictions he says align. He claims the therapeutic would cost patients about $5,000/year (~98% cheaper than current drugs), offers the paper as proof-of-work for other enzyme/peptide candidates, and invites biotech collaboration.

Source evidence

I'm publishing my Alzheimer's enzyme research. I started looking for a cure, didn't find it, but I think this is on the right track.

Hopefully a chaperonin lab has some spare time to put this on the bench. The bio-chemistry homework is real, predictions are in line. I lay no claim to ownership, Alzheimer's is a disease we must cure.

This enzyme or one like it would cost patients ~$5k/year, about a 98% discount from current drug options.

The paper should also serve as proof of work for my other enzyme/peptide work. If you are a biotech firm/researcher feel free to reach out. I have plenty of unpublished and much more promising candidates across peptides, enzymes and drug sequences.

Beaver 🦁 (@beaverd)

I invented a nitrogen fixation enzyme that works on sunlight and makes Haber-Bosch obsolete

k_cat at 1 atm: ~9,000 N2/site/sec

I have no idea how to sell it so I guess i'll just open source it and forgo the nobel prize?

— https://nitter.net/beaverd/status/2052899769815560418#m